Michael Leo to Graves Ophthalmopathy
This is a "connection" page, showing publications Michael Leo has written about Graves Ophthalmopathy.
Connection Strength
0.679
-
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy. J Endocrinol Invest. 2021 Mar; 44(3):581-585.
Score: 0.188
-
Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study. J Endocrinol Invest. 2020 Dec; 43(12):1717-1722.
Score: 0.186
-
Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory study. J Endocrinol Invest. 2018 Dec; 41(12):1417-1423.
Score: 0.163
-
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy. J Endocrinol Invest. 2016 Nov; 39(11):1323-1327.
Score: 0.143